Enfusion promotes Dan Groman to chief technology officer



NEW YORK and LONDON and HONG KONG, July 20, 2021 / PRNewswire / – Enfusion, the leading provider of cloud-based investment management software and services, today announced the promotion of Dan Groman from Co-Head of Technology to Chief Technology Officer (CTO). In his role, Groman will lead all software development, product management, IT and security teams in driving strategic technology development and innovation to maximize the impact of Enfusion as as a solutions partner for institutional investment managers and hedge funds.

“We are delighted that Dan is assuming this new role as we embark on the next phase of our growth and innovation roadmap,” said Thomas kim, CEO of Enfusion. “From day one, Dan’s unmatched enthusiasm for technology has enabled him to design value-added solutions that solve our customers’ biggest challenges in meaningful ways instead of just creating widgets. He has a good reputation. established to be a forward thinking forward. with deep product expertise. As CTO, Dan will continue to accelerate the innovation of our platform and our cloud native services not only to help our customers to solve the operational challenges they face today, but to prepare them for a prosperous and evolving future.

Groman joined Enfusion in 2016 as a software developer and has been instrumental in building Enfusion’s data warehouse, coding solutions and leading initiatives across all areas of software engineering. , including leading the proof of concept for the company’s visual analysis platform and building the engineering training program. Since then, he has worked closely with founding partners to manage Enfusion’s software development teams and lead IT and security teams globally. Prior to joining Enfusion, Groman was a systems engineer at CME Group, working on the exchange’s system infrastructure. Groman began his career in middle and back office operations for institutional managers, holding positions at Northern Trust Hedge Fund Services and King Street Capital Management.

“Enfusion brings a truly differentiated approach to investment management technology and services and I am honored to lead a stellar team of technologists and product managers who are dedicated to taking Enfusion to the next level with our robust, reliable and reliable solution. risk-proof, ”says Groman. “Enfusion’s pioneering story of building agile cloud-native SaaS solutions on a dataset, long before the cloud was mainstream, has been a great inspiration to me. I look forward to building on this foundation, turning cutting edge technology into a strategic asset for our clients and continuing to improve the efficiency of the investment workflow for fund managers around the world. ”

Groman’s promotion to CTO comes after a period of record growth for Enfusion. The company signed 160 new fund managers to the platform in 2020 and has seen triple-digit year-over-year customer base growth in APAC. Enfusion currently serves more than 600 clients in nine global offices.

About Enfusion
Enfusion’s investment management software platform as a service breaks down traditional information boundaries, uniting front, middle and back office teams on a cloud-native system and across a benchmark dataset . Using our industry-leading middle / back-office software, analytics and managed services, we create enterprise-wide, real-time, data-driven intelligence cultures that enhance agility and fueling growth.

As a FinTech leader and pioneer in the development of innovative solutions, Enfusion partners with more than 600 investment managers from nine global offices spread over four continents. In 2021, Enfusion was named Best EMS / OMS Provider by the Fund Intelligence Operations and Services Awards and Best Institutional Investment Solution at the FinTech Breakthrough Awards. For more information on its technology and managed services capabilities, visit: https://www.enfusion.com/.

View original content: https://www.prnewswire.com/news-releases/enfusion-promotes-dan-groman-to-chief-technology-officer-301337611.html

SOURCE Infusion Systems



Leave A Reply